Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
Clinical trial NCT01523171 · TERMINATED
Trial details
- NCT number
- NCT01523171
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-30
- Primary completion
- 2014-04-30
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.